Akari Therapeutics Plc P/L
Qual é o P/L de Akari Therapeutics Plc?
O P/L de Akari Therapeutics Plc é 0.00
Qual é a definição de P/L?
A razão entre preço e lucro é a razão entre o preço das ações de uma empresa e o lucro por ação da empresa, calculado ao longo de doze meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/L de empresas na Setor Health Care em NASDAQ em comparação com Akari Therapeutics Plc
O que Akari Therapeutics Plc faz?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Empresas com p/l semelhantes a Akari Therapeutics Plc
- Richland Resources International tem P/L de N/A
- Safeplus International tem P/L de N/A
- China Yanyuan Yuhui Natl Ed Grp tem P/L de N/A
- Acusphere tem P/L de N/A
- American Oriental Bioengineering tem P/L de N/A
- Gourmet Provisions International tem P/L de N/A
- Akari Therapeutics Plc tem P/L de 0.00
- SEL Manufacturing tem P/L de 0.00
- China Zhong Qi Hldgs tem P/L de 0.00
- MedSmart tem P/L de 0.00
- Panbela Therapeutics tem P/L de 0.00
- Epic tem P/L de 0.00
- 2574 tem P/L de 0.00